M&A Deal Summary

Sandoz International Acquires Aspen Global - Japanese Operations

On November 11, 2019, Sandoz International acquired life science company Aspen Global - Japanese Operations from Aspen Global for 6.5B ZAR

Acquisition Highlights
  • This is Sandoz International’s 2nd transaction in the Life Science sector.
  • This is Sandoz International’s 3rd largest (disclosed) transaction.
  • This is Sandoz International’s 1st transaction in Japan.

M&A Deal Summary
Date 2019-11-11
Target Aspen Global - Japanese Operations
Sector Life Science
Buyer(s) Sandoz International
Sellers(s) Aspen Global
Deal Type Divestiture
Deal Value 6.5B ZAR

Target

Aspen Global - Japanese Operations

Japan
Aspen Global, Inc.'s Japanese Operations is a provider of branded and generic pharmaceuticals.

Search 198,123 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sandoz International

Holzkirchen, Germany
Category Company
Sector Life Science
DESCRIPTION

Sandoz International GmbH is a developer, manufacturer and markets generic pharmaceutical products focused on biosimilars, injectables, inhalers and transdermal patches.

DEAL STATS #
Overall 3 of 5
Sector (Life Science) 2 of 4
Type (Divestiture) 2 of 4
Country (Japan) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-12-19 AmLactin

Maple Grove, Minnesota, United States

AmLactin is a developer, manufacturer of skin care products including therapeutic moisturizers and conditioners.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-02-11 GSK - Cephalosporin Antibiotics Business

Brentford, United Kingdom

GSK's Cephalosporin Antibiotics Business is a provider of antibiotics used to treat a range of bacterial infections.

Buy $500M

Seller(S) 1

SELLER

Aspen Global

Grand Bay, Mauritius
Category Company
Founded 2008
Sector Life Science
DESCRIPTION

South African-based Aspen is a supplier of branded and generic pharmaceuticals in more than 150 countries across the world and of consumer and nutritional products in selected territories. Aspen has production capabilities for a wide variety of product types including tablets, capsules, eye drops, injectable products (including lyophilized vials), oral contraceptives, form-filled seals, suppositories, liquids, creams, ointments, infant nutritional products, and specialist active pharmaceutical ingredients.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Divestiture) 2 of 2
Country (Japan) 1 of 1
Year (2019) 1 of 1
Size (of disclosed) 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-28 OTC Products

Grand Bay, Mauritius

OTC Products are primarily sold through the mass retail channel and include the Herron® range of analgesics, vitamins and supplements. This basket of products is expected to generate at least $20 million in annual revenue.

Sell $51M
Mergr

Product

Company

Legal